Friday, May 1, 2020

US hospitals using HCQ in treatment of COVID 19 patients May 01, 2020 at 06:54PM

MDedge, a medical publication, on Friday reported that hydroxychloroquine (HCQ) is currently the first-line therapy and Tocilizumab the second-line medication for people hospitalized with polymerase chain reaction-confirmed COVID-19 infection in the Yale New Haven Health System, which operates hospitals across Connecticut.

No comments:

Post a Comment